<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: How body size influences risk of molecular subtypes of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether measures of anthropometry differentially influence risk of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> according to BRAF c.1799T&gt;A p.V600E mutation (BRAF) and microsatellite instability (MSI) status </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Data from The Netherlands Cohort Study (n = 120,852) and Melbourne Collaborative Cohort Study (n = 40,514) were pooled and included 734 and 717 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases from each study, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Hazard ratios (HRs) and 95% confidence intervals (CIs) for body mass index (BMI), waist measurement and height were calculated and compared for subtypes defined by BRAF mutation and MSI status, measured from archival tissue </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Results were consistent between studies </plain></SENT>
<SENT sid="5" pm="."><plain>When pooled, BMI modelled in 5 kg/m(2) increments was positively associated with BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> (HR: 1.16, 95% CI: 1.08-1.26) and MS-stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (HR: 1.15, 95% CI: 1.06-1.24) </plain></SENT>
<SENT sid="6" pm="."><plain>Waist measurement was also associated with BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> (highest vs lowest quartile, HR: 1.59, 95% CI: 1.33-1.90) and MS-stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (highest vs lowest quartile HR: 1.68, 95% CI: 1.31-2.15) </plain></SENT>
<SENT sid="7" pm="."><plain>The HRs for BRAF mutation <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were smaller and non-significant, but differences between the HRs by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> subtypes were not significant </plain></SENT>
<SENT sid="8" pm="."><plain>Height, modelled per 5-cm increase, was positively associated with BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> and BRAF mutation <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, but the HR was greater for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with a BRAF mutation than BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> (HR: 1.23, 95% CI: 1.11-1.37, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>)â€‰= 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>Similar associations were observed with respect to height and MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (HR: 1.26, 95% CI: 1.13-1.40, P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.02) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Generally, overweight increases the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Taller individuals have an increased risk of developing a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> with a BRAF mutation or MSI </plain></SENT>
</text></document>